Status:
COMPLETED
A Study Comparing the Effectiveness and Convenience of Dietary Therapy for Irritable Bowel Syndrome (IBS)
Lead Sponsor:
Sheffield Teaching Hospitals NHS Foundation Trust
Conditions:
Irritable Bowel Syndrome
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Irritable bowel syndrome is a functional lower gastrointestinal disorder characterised by abdominal pain and altered bowel habit in the absence of organic pathology to explain the symptoms. Irritable ...
Eligibility Criteria
Inclusion
- Irritable Bowel syndrome - as defined by abdominal pain and altered bowel habit in the absence of organic pathology to explain the symptoms.This is the contemporary definition as provided by the Rome IV committee.
- Age 18-65 years
- English literate
- Can travel to hospital
- Telephone/internet access
Exclusion
- Inflammatory bowel disease
- Coeliac disease
- Gastrointestinal cancer
- Previous abdominal surgery
- Scleroderma
- Poorly controlled diabetes
- Severe liver disease
- Severe renal disease
- Severe respiratory disease
- Severe cardiac disease
- Severe psychiatric disease
- Memory disorders
- Pregnant
- Current dietary interventions
- Recent/current use of Probiotics
- Recent/current use of Antibiotics
- Recent/current use of Narcotics
- Currently titrated antidepressants (i.e. not on a stable dose)
Key Trial Info
Start Date :
April 18 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2021
Estimated Enrollment :
101 Patients enrolled
Trial Details
Trial ID
NCT04072991
Start Date
April 18 2019
End Date
November 30 2021
Last Update
April 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Hallamshire Hospital
Sheffield, South Yorkshire, United Kingdom, S10 2JF